• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吡唑-异吲哚酮和吡唑-吲哚共轭物作为抗糖尿病、抗关节炎和抗炎剂的体外酶促和计算评估

In Vitro Enzymatic and Computational Assessments of Pyrazole-Isatin and Pyrazole-Indole Conjugates as Anti-Diabetic, Anti-Arthritic, and Anti-Inflammatory Agents.

作者信息

Naglah Ahmed M, Almehizia Abdulrahman A, Ghazwani Mohammed, Al-Wasidi Asma S, Naglah Abdelrahman A, Aboulthana Wael M, Hassan Ashraf S

机构信息

Drug Exploration & Development Chair (DEDC), Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.

Department of Pharmaceutics, College of Pharmacy, King Khalid University, P.O. Box 1882, Abha 61441, Saudi Arabia.

出版信息

Pharmaceutics. 2025 Feb 23;17(3):293. doi: 10.3390/pharmaceutics17030293.

DOI:10.3390/pharmaceutics17030293
PMID:40142957
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11946580/
Abstract

: Recently, the prevalence of diseases such as diabetes, arthritis, and inflammatory diseases, along with their complications, has become a significant health problem. This is in addition to the various biomedical applications of pyrazole, isatin, and indole derivatives. Accordingly, cooperation will continue between chemistry scientists, pharmaceutical scientists, and human doctors to produce hybrid compounds from pyrazole with isatin or indole possessing biological activities as anti-diabetic, anti-arthritic, and anti-inflammatory agents. : The two series of pyrazole-isatin conjugates - and pyrazole-indole conjugates - were prepared from our previous works via the direct reaction of 5-amino-pyrazoles - with -alkyl isatin ,, and 1-indole-3-carbaldehyde (), respectively, using the previously reported procedure. The potential biological activities of - and - as anti-diabetic, anti-arthritic, and anti-inflammatory agents were assessed through estimated inhibition percentage (%) and the median inhibitory concentrations (IC) using methods described in the literature. Further, the computational assessments of - and - such as toxic doses (the median lethal dose, LD), toxicity classes, drug-likeness model scores (DLMS), molecular lipophilicity potential (MLP) maps, polar surface area (PSA) maps, and topological polar surface area (TPSA) values were predicted using available free websites. : The in vitro enzymatic assessment results showed that pyrazole-indole conjugate possesses powerful activities against (i) α-amylase (% = 65.74 ± 0.23, IC = 4.21 ± 0.03 µg/mL) and α-glucosidase (% = 55.49 ± 0.23, IC = 2.76 ± 0.01 µg/mL); (ii) the protein denaturation enzyme (% = 49.30 ± 0.17) and against the proteinase enzyme (% = 46.55 ± 0.17) with an IC value of 6.77 ± 0.01 µg/mL; (iii) the COX-1, COX-2, and 5-LOX enzymes with an IC of 5.44 ± 0.03, 5.37 ± 0.04, and 7.52 ± 0.04, respectively, which is almost close to the IC of the indomethacin and zileuton drugs. Also, the computational assessment results showed (i) the conjugate possesses lipophilic surface properties thus can cross cell membranes, and is effective for treatment; (ii) all the conjugates possess a TPSA value of more than 140 Å thus possess good intestinal absorption. : The two series of pyrazole-isatin conjugates - and pyrazole-indole conjugates - were synthesized from our previous works. The results of these in vitro enzymatic and computational assessments concluded that the pyrazole-indole conjugate possesses powerful activities against various studied enzymes and possesses good computational results. In the future, our research team will present in vitro, in vivo biological, and computational assessments to hopefully obtain effectual agents such as anti-diabetic, anti-arthritic, and anti-inflammatory.

摘要

最近,糖尿病、关节炎和炎症性疾病等疾病及其并发症的患病率已成为一个重大的健康问题。这还不包括吡唑、异吲哚酮和吲哚衍生物的各种生物医学应用。因此,化学科学家、制药科学家和医生之间将继续合作,以制备具有抗糖尿病、抗关节炎和抗炎剂等生物活性的吡唑与异吲哚酮或吲哚的杂化化合物。:通过我们之前的工作,分别使用先前报道的方法,通过5-氨基吡唑与烷基异吲哚酮和1-吲哚-3-甲醛的直接反应,制备了两系列吡唑-异吲哚酮共轭物和吡唑-吲哚共轭物。通过文献中描述的方法,通过估计抑制百分比(%)和半数抑制浓度(IC)评估了作为抗糖尿病、抗关节炎和抗炎剂的潜在生物活性。此外,使用可用的免费网站预测了的毒性剂量(半数致死剂量,LD)、毒性类别、药物相似性模型评分(DLMS)、分子亲脂性潜力(MLP)图、极性表面积(PSA)图和拓扑极性表面积(TPSA)值等计算评估。:体外酶促评估结果表明,吡唑-吲哚共轭物对(i)α-淀粉酶(% = 65.74 ± 0.23,IC = 4.21 ± 0.03 µg/mL)和α-葡萄糖苷酶(% = 55.49 ± 0.23,IC = 2.76 ± 0.01 µg/mL)具有强大的活性;(ii)对蛋白质变性酶(% = 49.30 ± 0.17)和蛋白酶(% = 46.55 ± 0.17),IC值为6.77 ± 0.01 µg/mL;(iii)对COX-1、COX-2和5-LOX酶的IC分别为5.44 ± 0.03、5.37 ± 0.04和7.52 ± 0.04,这几乎与消炎痛和齐留通药物的IC接近。此外,计算评估结果表明(i)共轭物具有亲脂性表面性质,因此可以穿过细胞膜,并且对治疗有效;(ii)所有共轭物的TPSA值均大于140 Å,因此具有良好的肠道吸收。:两系列吡唑-异吲哚酮共轭物和吡唑-吲哚共轭物是根据我们之前的工作合成的。这些体外酶促和计算评估的结果得出结论,吡唑-吲哚共轭物对各种研究的酶具有强大的活性,并且具有良好的计算结果。未来,我们的研究团队将进行体外、体内生物学和计算评估,以期获得抗糖尿病药、抗关节炎药和抗炎药等有效药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdbe/11946580/4d84b0e072be/pharmaceutics-17-00293-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdbe/11946580/47122c0f5773/pharmaceutics-17-00293-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdbe/11946580/6bd5425ff33d/pharmaceutics-17-00293-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdbe/11946580/2938293eaba3/pharmaceutics-17-00293-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdbe/11946580/cc0cba9223e8/pharmaceutics-17-00293-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdbe/11946580/ebb139a4b705/pharmaceutics-17-00293-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdbe/11946580/168060826f97/pharmaceutics-17-00293-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdbe/11946580/16198c95adfe/pharmaceutics-17-00293-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdbe/11946580/4d84b0e072be/pharmaceutics-17-00293-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdbe/11946580/47122c0f5773/pharmaceutics-17-00293-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdbe/11946580/6bd5425ff33d/pharmaceutics-17-00293-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdbe/11946580/2938293eaba3/pharmaceutics-17-00293-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdbe/11946580/cc0cba9223e8/pharmaceutics-17-00293-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdbe/11946580/ebb139a4b705/pharmaceutics-17-00293-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdbe/11946580/168060826f97/pharmaceutics-17-00293-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdbe/11946580/16198c95adfe/pharmaceutics-17-00293-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdbe/11946580/4d84b0e072be/pharmaceutics-17-00293-g007.jpg

相似文献

1
In Vitro Enzymatic and Computational Assessments of Pyrazole-Isatin and Pyrazole-Indole Conjugates as Anti-Diabetic, Anti-Arthritic, and Anti-Inflammatory Agents.吡唑-异吲哚酮和吡唑-吲哚共轭物作为抗糖尿病、抗关节炎和抗炎剂的体外酶促和计算评估
Pharmaceutics. 2025 Feb 23;17(3):293. doi: 10.3390/pharmaceutics17030293.
2
In Vitro Evaluation and Bioinformatics Analysis of Schiff Bases Bearing Pyrazole Scaffold as Bioactive Agents: Antioxidant, Anti-Diabetic, Anti-Alzheimer, and Anti-Arthritic.含吡唑骨架席夫碱作为生物活性物质的体外评价及生物信息学分析:抗氧化、抗糖尿病、抗老年痴呆症和抗关节炎。
Molecules. 2023 Oct 17;28(20):7125. doi: 10.3390/molecules28207125.
3
Design, Synthesis, Anticancer Evaluation, Enzymatic Assays, and a Molecular Modeling Study of Novel Pyrazole-Indole Hybrids.新型吡唑 - 吲哚杂化物的设计、合成、抗癌评估、酶活性测定及分子模拟研究
ACS Omega. 2021 Apr 29;6(18):12361-12374. doi: 10.1021/acsomega.1c01604. eCollection 2021 May 11.
4
Thiohydantoin derivatives incorporating a pyrazole core: Design, synthesis and biological evaluation as dual inhibitors of topoisomerase-I and cycloxygenase-2 with anti-cancer and anti-inflammatory activities.含吡唑核的硫代乙内酰脲衍生物的设计、合成及作为拓扑异构酶-I 和环氧化酶-2 双重抑制剂的生物评价:具有抗癌和抗炎活性。
Bioorg Chem. 2019 Oct;91:103132. doi: 10.1016/j.bioorg.2019.103132. Epub 2019 Jul 19.
5
Design, synthesis, modeling studies and biological evaluation of thiazolidine derivatives containing pyrazole core as potential anti-diabetic PPAR-γ agonists and anti-inflammatory COX-2 selective inhibitors.噻唑烷衍生物的设计、合成、建模研究及生物评价,该类噻唑烷衍生物以吡唑为核心,作为潜在的抗糖尿病 PPAR-γ 激动剂和抗炎 COX-2 选择性抑制剂。
Bioorg Chem. 2019 Feb;82:86-99. doi: 10.1016/j.bioorg.2018.09.034. Epub 2018 Sep 25.
6
Isatin-hydrazide conjugates as potent α-amylase and α-glucosidase inhibitors: Synthesis, structure and invitro evaluations.靛红酰肼类化合物作为有效的α-淀粉酶和α-葡萄糖苷酶抑制剂:合成、结构和体外评价。
Bioorg Chem. 2021 Nov;116:105385. doi: 10.1016/j.bioorg.2021.105385. Epub 2021 Sep 24.
7
Synthesis, ADMET prediction analysis, and pharmacological evaluation of sulfonamide derivatives tethered with pyrazole or pyridine as anti-diabetic and anti-Alzheimer's agents.作为抗糖尿病和抗阿尔茨海默病药物的、与吡唑或吡啶相连的磺酰胺衍生物的合成、ADMET预测分析及药理学评价
Saudi Pharm J. 2024 May;32(5):102025. doi: 10.1016/j.jsps.2024.102025. Epub 2024 Mar 12.
8
Discovery of novel thiazole derivatives containing pyrazole scaffold as PPAR-γ Agonists, α-Glucosidase, α-Amylase and COX-2 inhibitors; Design, synthesis and in silico study.发现新型噻唑衍生物,含吡唑骨架,作为 PPAR-γ 激动剂、α-葡萄糖苷酶、α-淀粉酶和 COX-2 抑制剂;设计、合成和计算机模拟研究。
Bioorg Chem. 2024 Nov;152:107760. doi: 10.1016/j.bioorg.2024.107760. Epub 2024 Aug 25.
9
Investigations of In Vitro Anti-Acetylcholinesterase, Anti-Diabetic, Anti-Inflammatory, and Anti-Cancer Efficacy of Garden Cress ( Linn.) Seed Extracts, as Well as In Vivo Biochemical and Hematological Assays.水芹(Linn.)种子提取物的体外抗乙酰胆碱酯酶、抗糖尿病、抗炎和抗癌功效研究以及体内生化和血液学检测
Pharmaceutics. 2025 Mar 31;17(4):446. doi: 10.3390/pharmaceutics17040446.
10
Design, synthesis, and molecular docking of novel pyrazole-chalcone analogs of lonazolac as 5-LOX, iNOS and tubulin polymerization inhibitors with potential anticancer and anti-inflammatory activities.新型吡唑查尔酮洛索洛芬类似物的设计、合成及分子对接作为潜在的抗癌和抗炎活性的 5-脂氧合酶、诱导型一氧化氮合酶和微管蛋白聚合抑制剂。
Bioorg Chem. 2022 Dec;129:106171. doi: 10.1016/j.bioorg.2022.106171. Epub 2022 Sep 22.

引用本文的文献

1
Investigations of In Vitro Anti-Acetylcholinesterase, Anti-Diabetic, Anti-Inflammatory, and Anti-Cancer Efficacy of Garden Cress ( Linn.) Seed Extracts, as Well as In Vivo Biochemical and Hematological Assays.水芹(Linn.)种子提取物的体外抗乙酰胆碱酯酶、抗糖尿病、抗炎和抗癌功效研究以及体内生化和血液学检测
Pharmaceutics. 2025 Mar 31;17(4):446. doi: 10.3390/pharmaceutics17040446.

本文引用的文献

1
Assessment of the In Vitro Biological Activities of Schiff Base-Synthesized Copper Oxide Nanoparticles as an Anti-Diabetic, Anti-Alzheimer, and Anti-Cancer Agent.席夫碱合成的氧化铜纳米颗粒作为抗糖尿病、抗阿尔茨海默病和抗癌剂的体外生物活性评估
Pharmaceutics. 2025 Feb 1;17(2):180. doi: 10.3390/pharmaceutics17020180.
2
Exploring the 3,5-Dibromo-4,6-dimethoxychalcones and Their Flavone Derivatives as Dual α-Glucosidase and α-Amylase Inhibitors with Antioxidant and Anticancer Potential.探索3,5-二溴-4,6-二甲氧基查尔酮及其黄酮衍生物作为具有抗氧化和抗癌潜力的双α-葡萄糖苷酶和α-淀粉酶抑制剂。
Antioxidants (Basel). 2024 Oct 17;13(10):1255. doi: 10.3390/antiox13101255.
3
Design, synthesis and potent anti-pancreatic cancer activity of new pyrazole derivatives bearing chalcone, thiazole and thiadiazole moieties: gene expression, DNA fragmentation, cell cycle arrest and SAR.
含查尔酮、噻唑和噻二唑基团的新型吡唑衍生物的设计、合成及其强效抗胰腺癌活性:基因表达、DNA片段化、细胞周期阻滞和构效关系
RSC Adv. 2024 Aug 27;14(37):26954-26970. doi: 10.1039/d4ra03005b. eCollection 2024 Aug 22.
4
Multicomponent reaction for synthesis, molecular docking, and anti-inflammatory evaluation of novel indole-thiazole hybrid derivatives.新型吲哚-噻唑杂化衍生物的合成、分子对接及抗炎评价的多组分反应
Mol Divers. 2024 Aug 15. doi: 10.1007/s11030-024-10969-8.
5
Phenolic Acid-β-Cyclodextrin Complexation Study to Mask Bitterness in Wheat Bran: A Machine Learning-Based QSAR Study.酚酸-β-环糊精络合作用研究以掩盖麦麸中的苦味:基于机器学习的定量构效关系研究
Foods. 2024 Jul 6;13(13):2147. doi: 10.3390/foods13132147.
6
A survey of isatin hybrids and their biological properties.异吲哚酮杂化物及其生物学特性的综述。
Mol Divers. 2025 Apr;29(2):1737-1760. doi: 10.1007/s11030-024-10883-z. Epub 2024 Jun 4.
7
-Heterocycles as Promising Antiviral Agents: A Comprehensive Overview.杂环化合物作为有前途的抗病毒药物:全面概述。
Molecules. 2024 May 10;29(10):2232. doi: 10.3390/molecules29102232.
8
Progress in Understanding Oxidative Stress, Aging, and Aging-Related Diseases.氧化应激、衰老及衰老相关疾病的研究进展
Antioxidants (Basel). 2024 Mar 25;13(4):394. doi: 10.3390/antiox13040394.
9
Synthesis, ADMET prediction analysis, and pharmacological evaluation of sulfonamide derivatives tethered with pyrazole or pyridine as anti-diabetic and anti-Alzheimer's agents.作为抗糖尿病和抗阿尔茨海默病药物的、与吡唑或吡啶相连的磺酰胺衍生物的合成、ADMET预测分析及药理学评价
Saudi Pharm J. 2024 May;32(5):102025. doi: 10.1016/j.jsps.2024.102025. Epub 2024 Mar 12.
10
Hybridization-based discovery of novel quinazoline-2-indolinone derivatives as potent and selective PI3Kα inhibitors.基于杂交技术发现新型喹唑啉-2-吲哚酮衍生物作为强效和选择性PI3Kα抑制剂
J Adv Res. 2025 Feb;68:459-475. doi: 10.1016/j.jare.2024.03.002. Epub 2024 Mar 11.